Professor Tomkin is a graduate of Trinity College Dublin. He trained as physician in General Medicine, Diabetes and Endocrinology. His special research interests are in the field of lipidology (cholesterol and triglycerides), atherosclerosis and diabetes.
He has written more than 100 papers in international peer-reviewed journals and has been invited to speak at many international meetings.
He has been president of the Association of Physicians of Great Britain and Ireland, vice president of the European Association for the Study of Diabetes and president of the Irish Endocrine Society and Irish Hyperlipidaemia associations.
He is past Chairman, and now President of the Diabetes Federation of Ireland. He is Director of the Diabetes Institute of Ireland at Beacon.
"Novartis are delighted to continue to support the Future Health Summit. The event is always high quality from its organisation to its speakers, and is a must attend event for anyone with an interest in improving healthcare and outcomes for patients"Ian Addie, Patient Access Head, Novartis Ireland Ltd
"‘Irish Heart would like to extend our thanks for having our mobile health unit attend the Future Health Summit. The mobile health unit was extremely well received and there was over 130 blood pressure checks taken over the two days,. The event was fantastic."Emma Carter ,Mobile Health Unit Manager ,Irish Heart
"‘I have spoken at and attended this event for the last six years and in a short space of time the Future Health Summit has become an annual meeting place for progressive healthcare leaders who want to drive change and improve healthcare delivery. "Mr. Bill Maher, Chief Executive, Bon Secours Health System
"“This Conference is another one of Ireland’s global contributions. The Future Health Summit is required attendance for all who wish to engage in a stimulating interchange on the future of healthcare – globally and domestically""Michael Dowling , Chief Executive Officer of Northwell Health